We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.04%
2 Financials 14.33%
3 Healthcare 12.99%
4 Industrials 10.19%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMC icon
1901
AMC Entertainment Holdings
AMC
$2.35B
$6.32M ﹤0.01%
87,283
+12,741
+17% +$1.12M
PRNB
1902
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$6.3M ﹤0.01%
115,068
+47,333
+70% +$1.77M
HAPN
1903
Happen Inc
HAPN
$2.27B
$6.28M ﹤0.01%
497,483
+18,084
+4% +$233K
MODN
1904
DELISTED
MODEL N, INC.
MODN
$6.28M ﹤0.01%
178,903
+8,627
+5% +$263K
ANIK icon
1905
Anika Therapeutics
ANIK
$283M
$6.27M ﹤0.01%
120,966
+3,179
+3% +$185K
TWOU
1906
DELISTED
2U Inc
TWOU
$6.27M ﹤0.01%
8,715
+303
+4% +$188K
HNGR
1907
DELISTED
Hanger Inc.
HNGR
$6.27M ﹤0.01%
227,108
+4,601
+2% +$109K
CHWY icon
1908
Chewy
CHWY
$9.2B
$6.26M ﹤0.01%
216,011
+3,826
+2% +$97.9K
DDD icon
1909
3D Systems Corp
DDD
$601M
$6.25M ﹤0.01%
713,989
+17,990
+3% +$156K
AERI
1910
DELISTED
Aerie Pharmaceuticals
AERI
$6.25M ﹤0.01%
258,394
+7,751
+3% +$161K
CMRE icon
1911
Costamare
CMRE
$1.74B
$6.21M ﹤0.01%
651,542
+58,441
+10% +$467K
RRC icon
1912
Range Resources
RRC
$9.33B
$6.2M ﹤0.01%
1,277,163
+141,189
+12% +$570K
SRCI
1913
DELISTED
SRC Energy Inc
SRCI
$6.2M ﹤0.01%
1,503,633
+32,961
+2% +$125K
GPMT
1914
Granite Point Mortgage Trust
GPMT
$58.8M
$6.18M ﹤0.01%
336,415
+7,928
+2% +$145K
OMAB icon
1915
Grupo Aeroportuario Centro Norte
OMAB
$5.19B
$6.18M ﹤0.01%
103,038
MLAB icon
1916
Mesa Laboratories
MLAB
$633M
$6.16M ﹤0.01%
24,707
+818
+3% +$192K
SLCA
1917
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$6.16M ﹤0.01%
1,001,321
+189,447
+23% +$1.14M
AORT icon
1918
Artivion
AORT
$1.39B
$6.15M ﹤0.01%
227,096
+4,019
+2% +$98.8K
CNR
1919
Core Natural Resources Inc
CNR
$4.64B
$6.14M ﹤0.01%
422,819
-56,550
-12% -$781K
BZH icon
1920
Beazer Homes USA
BZH
$874M
$6.13M ﹤0.01%
434,146
+68,451
+19% +$1.04M
CARO
1921
DELISTED
Carolina Financial Corp.
CARO
$6.11M ﹤0.01%
141,418
+15,030
+12% +$592K
CMCO icon
1922
Columbus McKinnon
CMCO
$550M
$6.1M ﹤0.01%
152,413
-5,120
-3% -$198K
ANIP icon
1923
ANI Pharmaceuticals
ANIP
$1.72B
$6.09M ﹤0.01%
98,793
+1,080
+1% +$71.5K
ASNA
1924
DELISTED
Ascena Retail Group, Inc.
ASNA
$6.09M ﹤0.01%
794,766
+245,448
+45% +$2.01M
SHOE
1925
Shoe Station Group
SHOE
$415M
$6.08M ﹤0.01%
325,940
+8,686
+3% +$154K

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.